A Career at the Forefront of Science

Mark Bouzyk, PhD, has spent over three decades leading breakthroughs in biotechnology, genetics, and precision medicine. From world-class research institutions to successful biotech startups, one principle has guided his work: science should serve people.

Mark began his career in the United Kingdom at a national biomedical research institute and a leading cancer research foundation, contributing to pioneering genetic research. These early experiences shaped his vision of using genetics as a bridge between the lab and real-world healthcare. His journey continued at a global pharmaceutical company, where he oversaw international teams and helped develop pharmacogenomics programs that changed the way medicine is prescribed.

In 2005, Mark joined a major U.S. research university to establish and direct a Center for Medical Genomics. He expanded research infrastructure and helped a leading cancer institute achieve its first-ever national cancer center designation — a milestone for the region. Known for mentorship as much as innovation, he created training programs and workshops that prepared the next generation of scientists to advance the field.

Mark co-founded an Inc. 500 genomics and biomarker company that became one of the fastest-growing firms in its field for three consecutive years. Under his leadership, the company secured multimillion-dollar contracts, including the landmark national veterans’ Million Veteran Program, one of the largest genomic and epigenomic studies ever conducted. Following the company’s successful acquisition by a global precision medicine and AI-driven healthcare firm, he continued shaping the future of precision medicine through a leading healthcare AI startup, developing AI-powered tools that improve patient care while easing the burden on physicians.

Mark’s impact extends far beyond labs and boardrooms. He helped establish the first major genetics laboratory in West Africa, provided support to launch a national genetic screening initiative in the U.S., and developed genetic tests to benefit the Ashkenazi Jewish community. He also supports over 20 animal welfare organizations reflecting his belief that compassion and science go hand in hand.

For Mark, every scientific innovation is an opportunity to increase access, reduce disparities, and improve lives. From advancing AI-driven healthcare solutions to building genomics infrastructure in underserved regions, his work blends discovery with humanity — ensuring that science matters not just in theory, but in practice.